Research never stops

Archive



Jul 24, 2017

Evotec and Bayer advance endometriosis programme into Phase I clinical development and extend alliance

Hamburg, Germany, 24 July 2017: Evotec AG announced today that its multi-target endometriosis alliance with Bayer has advanced a programme from the alliance portfolio into Phase I clinical development for the treatment of endometriosis, triggering a milestone payment to Evotec.

- read more
Jul 06, 2017

Evotec received funding from IFB Hamburg to identify antibody-mediated t-cell immunotherapies

Hamburg, Germany, 06 July 2017:
Evotec AG announced today that the Company has been awarded a 'Programm für Innovation' grant for a period of two years from the  Hamburgische Investitions- und Förderbank, the central development institution of the Free and Hanseatic city of Hamburg, to identify and develop therapeutic antibodies directed against novel immune-checkpoints on T-cells to improve future cancer treatments.

- read more
Jun 28, 2017

Evotec expands iPSC drug discovery leadership through strategic collaboration with Censo Biotechnologies

Hamburg, Germany, 28 June 2017: Evotec AG today announced a collaboration with Censo Biotechnologies Ltd. to source and provide patient-derived induced pluripotent stem cells to support Evotec's broad iPSC platform.

- read more
Jun 22, 2017

LAB282 accelerates with second round funding

Jun 20, 2017

Evotec announces strategic investment in Facio Therapies to support development of novel FSHD therapy

Jun 16, 2017

Evotec receives European Mediscience Award for 'Company of the Year'

Jun 14, 2017

Resolutions of the Annual General Meeting 2017 of Evotec AG

Jun 14, 2017

Evotec joins NURTuRE consortium to mine unique kidney disease patient biobank

May 22, 2017

Evotec receives pre-clinical milestone as part of its Endometriosis Alliance with Bayer

May 10, 2017

Evotec announces first quarter results 2017 and corporate update

Apr 05, 2017

Evotec achieves first milestone in Diabetes alliance with Sanofi

Mar 31, 2017

EvotecĀ“s partner Forge Therapeutics receives prestigious Carb-X research award

Mar 28, 2017

Evotec fiscal year results 2016: Leading innovation efficiency & First-in-class drug discovery

Mar 03, 2017

Great story - Short film

Please click here and enjoy.

- read more
Feb 21, 2017

Evotec AG: 'LAB282' awarded first projects

Feb 09, 2017

Novo A/S becomes new long-term strategic shareholder in Evotec

Jan 26, 2017

Cyprotex, an Evotec company, expands into new UK facility at Alderley Park

Jan 19, 2017

Evotec enters into an integrated drug discovery collaboration with Asahi Kasei Pharma (Japan)

Jan 17, 2017

Evotec and MaRS Innovation establish strategic partnership to launch Fibrocor Therapeutics

Jan 12, 2017

HaplogenĀ“s novel antiviral target partnered with Evotec published in 'Nature'

Jan 09, 2017

Evotec and Eternygen to develop novel metabolic disease therapy